Yasuhiro Miki - Gynecology

Author Information

Yasuhiro Miki is affiliated with the Disaster Obstetrics and Gynecology Lab at the International Research Institute of Disaster Science (IRIDeS), Tohoku University, located in Sendai, Japan. His research focuses on the intersection of gynecology and disaster management, aiming to improve health management for women during disasters. Miki's work is pivotal in understanding the unique vulnerabilities women face in such situations and developing appropriate health management strategies.

Research Contributions

Yasuhiro Miki has made significant contributions to various fields including gynecology, oncology, and disaster health management. In 2022, he published papers on topics such as the health management of women during disasters, the efficacy of tamoxifen treatment in breast cancer, and the roles of various biomarkers in cancer prognosis. His research also delves into the molecular interactions and prognostic factors in cancers such as non-small cell lung carcinoma and endometrial cancer. Miki's work often intersects gynecology with broader health issues, including breast cancer and diabetes, providing a holistic view of women's health.

Aliases

Y. Miki, Yasuhiro Miki

Publication and Citation Metrics

Metric	Value
Citation Count	6879
H-Index	45
Paper Count	249

Publications:

Appropriate Health Management Considering the Vulnerability of Women during Disasters.

DOI: 10.1620/tjem.256.187

Year: 2022

FE65 defines the efficacy of tamoxifen treatment via osteopontin expression in estrogen receptor-positive breast cancer.

DOI: 10.1016/j.prp.2022.153898

Year: 2022

Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors

DOI: 10.1016/j.prp.2022.153758

Year: 2022

Immunolocalization of CD80 and CD86 in Non-Small Cell Lung Carcinoma: CD80 as a Potent Prognostic Factor

DOI: 10.1267/ahc.21-00075

Year: 2022

Co-expression of nuclear heterogeneous nuclear ribonucleic protein K and estrogen receptor α in endometrial cancer.

DOI: 10.1016/j.prp.2022.153795

Year: 2022

Breast Cancer, Diabetes Mellitus And Glucagon-Like Peptide-1 Receptor Toward Exploring Their Possible Associations

DOI: 10.21203/RS.3.RS-370359/V1

Year: 2021

The Visualization of Protein-Protein Interactions in Breast Cancer: Deployment Study in Pathological Examination

DOI: 10.1267/ahc.21-00084

Year: 2021

Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations

DOI: 10.1007/s10549-021-06380-8

Year: 2021

B7‐1 and programmed cell death‐ligand 1 in primary and lymph node metastasis lesions of non‐small cell lung carcinoma

DOI: 10.1002/cam4.4444

Year: 2021

EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer

DOI: 10.3390/ijms22168522

Year: 2021

How Can Dietitians Support Women with Menopause?

What are the considerations for prescribing gynecological medications?

What Are Immunological Causes of Recurrent Pregnancy Loss?

What are Subdermal Contraceptive Implants?

How is Placental Dysfunction Managed?

What are the implications of polycystic ovary syndrome (PCOS) research?

What are Common Treatments?

What are the Prognosis and Outcomes?

Can Burning Sensation Affect Sexual Health?

How are Genital Warts Transmitted?

Partnered Content Networks

Relevant Topics